e-learning
resources
Stockholm 2007
Saturday 15.09.2007
PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary biomarkers in asthma and COPD
P. Montuschi (Rome, Italy)
Source:
Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Session:
PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Session type:
Postgraduate Course
Number:
142
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Montuschi (Rome, Italy). Pulmonary biomarkers in asthma and COPD. Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004
Cardiac biomarkers and outcomes of COPD exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004
COPD and other pulmonary diseases
Source: Eur Respir Monogr 2015; 67: 161-178
Year: 2015
Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Exacerbations of asthma and COPD
Source: ERS Skills Course 2016
Year: 2016
Exacerbations of asthma and COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Exacerbations of asthma and COPD
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Pulmonary rehabilitation and exacerbations of COPD
Source: Eur Respir Monogr 2021; 93: 165-181
Year: 2021
Pulmonary vascular remodelling in COPD versus bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Pulmonary functional diagnosis of COPD
Source: Virtual Congress 2020 – Russian speaking programme 2020: Part I
Year: 2020
Asthma and smoking-induced airway disease without spirometric COPD
Source: Eur Respir J, 49 (5) 1602061; 10.1183/13993003.02061-2016
Year: 2017
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Lung hyperinflation in COPD and asthma
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
COPD
Source: ERS Skills Course 2016
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept